STR-P004
/ Starna Therap
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
November 25, 2025
To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004
(clinicaltrials.gov)
- P=N/A | N=11 | Not yet recruiting | Sponsor: Starna Therapeutics
New trial • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology
August 28, 2025
Exploratory Clinical Study on the Safety of STR-P004 in the Treatment of Patients With Relapsed or Refractory Autoimmune Diseases
(clinicaltrials.gov)
- P=N/A | N=39 | Not yet recruiting | Sponsor: Beijing GoBroad Hospital
New trial • Immunology
June 04, 2025
A Study to Evaluate the Safety and Clinical Efficacy of STR-P004
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Starna Therapeutics
New P1 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 3
Of
3
Go to page
1